Macroaxis does not monitor all media channels or aggregates social signals for Infinity Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Infinity Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Infinity Pharmaceuticals. Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance
BZ WeeklyFavorable Media Coverage Somewhat Unlikely to Impact Infinity Pharmaceuticals Stock Price The Ledger GazetteInfinity Pharmaceuticals, Inc. Analysts See -0.25 EPS Frisco Fastball Get full coverage
Post Analyst Get full coverage
KL DailyInfinity Pharmaceuticals, Inc. Analysts See -0.25 EPS Frisco FastballThere Is Something To Be Excited About Infinity Pharmaceuticals, Inc. , Zynga Inc. Post Analyst Get full coverage
Technical analysis of Infinity Pharmaceuticals, Inc. stock includes the study of technical indicators and past trends.
FactsReporterInfinity Pharmaceuticals, Inc. A Detailed Look at its Institutional Ownership Post AnalystInfinity Pharmaceuticals Incorporated on Focus After Report of Less Shorts BZ Weekly Get full coverage
Novavax, Inc. and Infinity Pharmaceuticals, Inc. are both Healthcare companies that recently hit new highs.
UtahHerald.comInfinity Pharmaceuticals Given Daily Media Impact Score of 0.11 Dispatch TribunalAs Gilead Sciences Shares Declined, Monarch Capital Management Has Raised Holding by 321975 Platinum ... Herald KS Get full coverage
Analysts expect Infinity Pharmaceuticals, Inc. to report -0.25 EPS on March, 13.They anticipate 0.21 EPS change or 45.65 percent from last quarter -0.46 EPS. General Electric Co Shareholder Lakeview Capital Partners Decreased Its ... - Thorold News Carlson Capital Management Holding in Apple Decreased as Share Price ... - NormanObserver.com
Infinity Pharmaceuticals logo Clear Harbor Asset Management LLC acquired a new position in Infinity Pharmaceuticals Inc. in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. EPS for Infinity Pharmaceuticals, Inc. Expected At -0.25 Hawaiian ... - UtahHerald.com Infinity Pharmaceuticals, Inc. Reaches 2.08 After 7.00 percent Up Move Tenet ... - NormanObserver.com
CAMBRIDGE, Mass., Feb. 5, 2018 PRNewswire -- Infinity Pharmaceuticals, Inc. announced today that Adelene Perkins, Infinity Pharmaceutical chief executive officer, will present at the BIO CEO and Investor Conference on Monday, February ...
Filed transaction by Infinity Pharmaceuticals officer. Unconventional Insider trading
The Return on Invested Capital Score for Infinity Pharmaceuticals, Inc. is -1.261285. The Return on Invested Capital is a ratio that determines whether a company is profitable or not.
Altria Group, Inc. has made its way to a 12-month decline of -1.18. Turning to Infinity Pharmaceuticals, Inc. , its shares were trading at 2.05 a retreat of -0.01, on the trading floor.
Post AnalystWhat Analysts Say Infinity Pharmaceuticals, Inc. stock closes Yesterday with -3.74 Nasdaq Fortune Infinity Pharmaceuticals Receiving Somewhat Positive Press Coverage, Analysis Shows The Lincolnian Online Get full coverage
We can also take a look at some stock volatility data on shares of Infinity Pharmaceuticals, Inc. . The 12 month volatility is currently 100.668400.